Tamasi Viola, Miller Kristy K Michael, Ripp Sharon L, Vila Ermin, Geoghagen Thomas E, Prough Russell A
Department of Biochemistry and Molecular Biology, U. Louisville School of Medicine, Louisville, KY 40292, USA.
Mol Pharmacol. 2008 Mar;73(3):968-76. doi: 10.1124/mol.107.036780. Epub 2007 Dec 13.
Dehydroepiandrosterone (DHEA), a C19 human adrenal steroid, activates peroxisome proliferator-activated receptor alpha (PPARalpha) in vivo but does not ligand-activate PPARalpha in transient transfection experiments. We demonstrate that DHEA regulates PPARalpha action by altering both the levels and phosphorylation status of the receptor. Human hepatoma cells (HepG2) were transiently transfected with the expression plasmid encoding PPARalpha and a plasmid containing two copies of fatty acyl coenzyme oxidase (FACO) peroxisome-proliferator activated receptor responsive element consensus oligonucleotide in a luciferase reporter gene. Nafenopin treatment increased reporter gene activity in this system, whereas DHEA treatment did not. Okadaic acid significantly decreased nafenopin-induced reporter activity in a concentration-dependent manner. Okadaic acid treatment of primary rat hepatocytes decreased both DHEA- and nafenopin-induced FACO activity in primary rat hepatocytes. DHEA induced both PPARalpha mRNA and protein levels, as well as PP2A message in primary rat hepatocytes. Western blot analysis showed that the serines at positions 12 and 21 were rapidly dephosphorylated upon treatment with DHEA and nafenopin. Results using specific protein phosphatase inhibitors suggested that protein phosphatase 2A (PP2A) is responsible for DHEA action, and protein phosphatase 1 might be involved in nafenopin induction. Mutation of serines at position 6, 12, and 21 to an uncharged alanine residue significantly increased transcriptional activity, whereas mutation to negative charged aspartate residues (mimicking receptor phosphorylation) decreased transcriptional activity. DHEA action involves induction of PPARalpha mRNA and protein levels as well as increased PPARalpha transcriptional activity through decreasing receptor phosphorylation at serines in the AF1 region.
脱氢表雄酮(DHEA)是一种C19人类肾上腺类固醇,在体内可激活过氧化物酶体增殖物激活受体α(PPARα),但在瞬时转染实验中不能通过配体激活PPARα。我们证明,DHEA通过改变受体的水平和磷酸化状态来调节PPARα的作用。将编码PPARα的表达质粒和一个在荧光素酶报告基因中含有两个脂肪酸辅酶氧化酶(FACO)过氧化物酶体增殖物激活受体反应元件共有寡核苷酸拷贝的质粒瞬时转染人肝癌细胞(HepG2)。在该系统中,萘酚平处理可增加报告基因活性,而DHEA处理则无此作用。冈田酸以浓度依赖的方式显著降低萘酚平诱导的报告基因活性。用冈田酸处理原代大鼠肝细胞可降低DHEA和萘酚平诱导的原代大鼠肝细胞中的FACO活性。DHEA可诱导原代大鼠肝细胞中PPARα的mRNA和蛋白水平以及PP2A的mRNA水平。蛋白质印迹分析表明,用DHEA和萘酚平处理后,第12和2l位的丝氨酸迅速去磷酸化。使用特异性蛋白磷酸酶抑制剂的结果表明,蛋白磷酸酶2A(PP2A)负责DHEA的作用,蛋白磷酸酶1可能参与萘酚平的诱导作用。将第6、12和21位的丝氨酸突变为不带电荷的丙氨酸残基可显著增加转录活性,而突变为带负电荷的天冬氨酸残基(模拟受体磷酸化)则降低转录活性。DHEA的作用包括诱导PPARα的mRNA和蛋白水平,以及通过降低AF1区域丝氨酸处的受体磷酸化来增加PPARα的转录活性。